US Broker Ratings

SS Innovations International (SSII) Stock Analysis: A Surgical Robotics Pioneer with Impressive Revenue Growth

SS Innovations International Inc. (NASDAQ: SSII) is making waves in the healthcare sector with its innovative approach to surgical robotics. Headquartered in Gurugram, India, the company has carved a niche..

Clover Health Investments Corp (CLOV): Investor Outlook Reveals 15.30% Potential Upside in Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) continues to capture the attention of investors within the healthcare sector. Specializing in Medicare Advantage plans, Clover Health offers innovative healthcare solutions through its..

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a 24.59% Potential Upside

agilon health, inc. (NYSE: AGL) stands as a unique player in the healthcare sector, specifically within medical care facilities, focusing on providing healthcare services to seniors through primary care physicians..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A 12% Potential Upside in the Healthcare Sector

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) has carved a niche for itself in the healthcare sector, specifically within the medical care facilities industry. As an Atlanta-based company, Guardian Pharmacy Services..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Exploring an 84.83% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is gaining attention in the biotechnology sector with its focused mission to develop groundbreaking treatments for rare diseases. This Princeton, New Jersey-based firm, established in..

Evolent Health, Inc (EVH) Stock Analysis: A 99% Potential Upside with Strong Buy Ratings

Evolent Health, Inc. (NYSE: EVH) stands out in the healthcare sector, specifically within the Health Information Services industry, as an intriguing investment opportunity. With a market capitalization of $899.94 million,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Biotech Innovator with 79.94% Potential Upside

Ocular Therapeutix, Inc. (OCUL), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach in developing therapies for retinal diseases and other eye conditions. Headquartered..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unlocking a 40% Potential Upside in Healthcare

The Pennant Group, Inc. (NASDAQ: PNTG) is gaining attention among investors with its strong potential upside of 40% based on current analyst projections. Operating in the healthcare sector, the company..

Kestra Medical Technologies (KMTS) Stock Report: Healthcare Innovator with a 51.5% Revenue Growth

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a prominent player in the healthcare sector, is capturing investor attention with its impressive revenue growth and innovative approach to cardiovascular healthcare. Founded in..

Harrow, Inc. (HROW) Stock Analysis: Exploring a 61.82% Upside Potential in the Specialty Pharma Sector

In the vibrant landscape of the healthcare sector, Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors with its bold prospects. Specializing in ophthalmic pharmaceuticals, Harrow is strategically positioned..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 36.40% Potential Upside in the Healthcare Sector

Astrana Health Inc. (ASTH), a prominent player in the medical care facilities industry, is catching the attention of investors with a compelling potential upside of 36.40%, according to recent analyst..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 98% Upside Potential in Regenerative Medicine

Mesoblast Limited (MESO), a key player in the biotechnology industry, is capturing investor attention with its significant potential upside of 98.30% based on current analyst ratings. Headquartered in Melbourne, Australia,..

Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals 126.53% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, is capturing the attention of investors with a compelling potential upside of 126.53%. Specializing in the development and..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Promising 12.49% Upside in the Healthcare Sector

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector, particularly in the niche of drug manufacturing – both specialty and generic – presents an intriguing opportunity for..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unlocking a 25.98% Potential Upside in the Healthcare Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector specializing in non-opioid pain management solutions, presents an intriguing opportunity for investors. With a current market cap of..

Amphastar Pharmaceuticals, Inc. (AMPH): Analyst Consensus Suggests 36.96% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a dynamic player in the healthcare sector, specializes in the development and distribution of both generic and proprietary injectable, inhalation, and intranasal products. With a..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 13% Upside Beckons Amid Strong Buy Ratings

Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing the attention of investors with its promising growth potential in the healthcare sector, specifically within the medical devices industry. Headquartered in Alajuela,..

Haemonetics Corporation (HAE) Stock Analysis: Evaluating a 50% Upside Potential in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector specializing in medical devices, is drawing considerable attention from investors due to its potential upside of 50.41%. With a..

Integra LifeSciences Holdings (IART): Investor Outlook with a Focus on Its 4.37% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, has piqued investor interest with its significant upside potential and strategic positioning in the healthcare industry...

Novavax, Inc. (NVAX) Stock Analysis: Examining the 42% Potential Upside Amidst Biotechnology Challenges

Investors in the biotechnology sector are likely familiar with Novavax, Inc. (NASDAQ: NVAX), a company that has become a prominent name in vaccine development. With a current market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds